| Filed On | Filing |
|---|---|
| 14 Oct 2026 |
8-K/A: Financial Statements and Exhibits
On July 31, 2026, Palomino Laboratories Inc. (“Palomino” or the “Company”) entered into a Share Exchange Agreement and Plan of Reorganization (the “Share Exchange Agreement”) with Vega Links, Inc. (“Vega Links” or “VLI”) and the stockhol... |
| 08 Oct 2026 | Proxy statement: annual meeting on November 5, 2026 |
| 28 Sep 2026 | PRE 14A |
| 21 Aug 2026 | SCHEDULE 13D/A |
| 05 Aug 2026 | 8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +1 more |
| 05 Aug 2026 | 10-Q |
| 04 Aug 2026 |
Form 4: Ogawa Richard, Director
Acquired 120,000 shares (Other Transaction) ($617K) |
| 16 Jul 2026 | 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure |
| 15 May 2026 | 10-Q |
| 05 May 2026 | 8-K: Unregistered Sales of Equity Securities |
| 01 May 2026 | D |
| 24 Apr 2026 | 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities |
| 20 Apr 2026 |
Form 4: Ogawa Richard, Director
Bought 12,500 shares ($50K) |
| 20 Apr 2026 |
Form 4: Denbaars Steven, Director
Bought 12,500 shares ($50K) |
| 09 Apr 2026 | 8-K: Other Events |
| 31 Mar 2026 | 10-K |
| 12 Feb 2026 | 424B3 |
| 09 Feb 2026 | EFFECT |
| 05 Feb 2026 | CORRESP |
| 23 Jan 2026 | S-1 |
Loading...
